COMPARISON OF DIHYDROERGOTAMINE WITH METOCLOPRAMIDE VERSUS MEPERIDINE WITH PROMETHAZINE IN THE TREATMENT OF ACUTE MIGRAINE

被引：40

作者：

SCHERL, ER

WILSON, JF

机构：

[1] UNIV KENTUCKY,COLL MED,DEPT INTERNAL MED,DIV GEN INTERNAL MED,LEXINGTON,KY

[2] UNIV KENTUCKY,COLL MED,DEPT BEHAV SCI,LEXINGTON,KY

来源：

HEADACHE | 1995年 / 35卷 / 05期

关键词：

MIGRAINE; HEADACHE; DIHYDROERGOTAMINE; METOCLOPRAMIDE; MEPERIDINE; PROMETHAZINE;

D O I：

10.1111/j.1526-4610.1995.hed3505256.x

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Migraineurs often seek office-based treatment for acute headache. To compare the efficacy and side effect profile, we entered 27 migraineurs into a prospective, randomized, double-blind study where each patient received either 75 mg meperidine with 25 mg promethazine IM or .5 mg dihydroergotamine with 10 mg metoclopramide IV. After 1 hour, pain relief was similar in the two groups, but side effects were significantly greater in the meperidine with promethazine regimen group. The dihydroergotamine with metoclopramide regimen is effective, and has minimal side effects, making it an attractive method for office-based treatment of acute migraine.

引用

页码：256 / 259

页数：4

共 10 条

[1] COMPARISON OF SINGLE-DOSE MEPERIDINE, BUTORPHANOL, AND DIHYDROERGOTAMINE IN THE TREATMENT OF VASCULAR HEADACHE [J].